Atlas Prime

Lam ResearchLRCX

Lam Research Corporation is a prominent supplier of equipment vital for semiconductor processing, encompassing its design, production, sales, repair, and ongoing maintenance. These sophisticated systems are fundamental for the creation of integrated circuits. The company's extensive product catalog features a variety of deposition technologies. For tungsten metallization, they provide ALTUS systems that deposit conformal films. SABRE products excel in electrochemical deposition, crucial for copper interconnect transitions and enabling copper damascene manufacturing. SOLA utilizes ultraviolet thermal processing for film treatments, while VECTOR delivers plasma-enhanced chemical vapor deposition (CVD) and atomic layer deposition (ALD) solutions. Furthermore, SPEED addresses gapfill applications with its high-density plasma CVD products, and Striker is engineered for single-wafer atomic layer deposition of dielectric films. Beyond deposition, Lam Research offers a comprehensive suite of etching tools. Flex is designed for dielectric etch applications, Kiyo handles conductor etch processes, Syndion specializes in through-silicon via etching, and Versys metal products are used for metal etch processes. The company's offerings also extend to specialized solutions like Coronus, which enhances die yield through bevel cleaning. For various wafer cleaning requirements, Lam Research supplies multiple product lines, including Da Vinci, DV-Prime, EOS, and SP series. Additionally, Metryx mass metrology systems provide precise, in-line mass measurement capabilities for semiconductor wafer manufacturing. Lam Research serves the global semiconductor industry, distributing its technologies and services across the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and other international markets. Established in 1980, the company maintains its corporate headquarters in Fremont, California.

Last
$267.61
1D
2.5%
1W
1.5%
1M
19.1%
Next earnings: October 21, 2026

Research memo

Lam Research (LRCX) closed at $267.61 on April 17, up 2.55% on the day and 19.09% over the past month. The tape is saying the wafer-fabrication equipment recovery is no longer just a timing call; investors are leaning into the next semiconductor capital-spending upswing before end-demand is fully clean. Greed is back in the market, and Lam has been one of the ways to express a stronger memory and leading-edge spend cycle.

Hard data

  • Price: $267.61
  • 1-day move: +2.55%
  • 1-week move: +1.5%
  • 1-month move: +19.09%
  • Fear & Greed Index: 69 (Greed)
  • Market cap: $377.5B
  • Enterprise value: $376.1B
  • Revenue: $23.2B
  • Gross margin: 51.7%
  • Next revenue growth: 4.2%
  • EV/revenue: 16.2x

Thesis

Lam Research sells the etch and deposition tools that let chipmakers carve and build the layers inside advanced semiconductors. The stock already prices in a wafer-fabrication equipment rebound, so the debate is not whether spending returns; it is whether process complexity at leading-edge logic and advanced memory keeps rising enough to drive more tool steps, a better consumables mix, and more service leverage over the next 12 to 18 months. The strongest pushback is that this is still a capital-spending cycle, and a pause in foundry or memory budgets can hit orders fast. Fair. But consensus still looks too low on how much artificial intelligence build-outs and advanced node transitions raise process intensity, which can keep bookings, backlog, and margins moving higher even if end-demand stays uneven.

Bear case

The bear case is a classic semiconductor equipment rollover. If foundry spending slows, non-volatile memory spending stays weak, or customers delay the next node transition, Lam’s order growth can stall fast and the multiple can compress even with a strong franchise. Customer concentration, budget timing, and shipment slippage can all turn one weak quarter into a sentiment reset.

Invalidation

The setup breaks if bookings and backlog stop improving for more than one quarter, or if management points to a material pause in customer spending that pushes the recovery materially out. Sustained weakness in foundry or non-volatile memory capex would also kill the thesis.

Trade framing

If volatility stays elevated while the stock has already re-rated, the cleaner expression is usually to own pullbacks rather than chase upside. The setup still favors upside participation over outright contraction risk, but after a 19% one-month move the market will punish any disappointment in order momentum quickly.